Loss of GCN5L1 in cardiac cells disrupts glucose metabolism and promotes cell death via reduced Akt/mTORC2 signaling.


Journal

The Biochemical journal
ISSN: 1470-8728
Titre abrégé: Biochem J
Pays: England
ID NLM: 2984726R

Informations de publication

Date de publication:
19 06 2019
Historique:
received: 23 04 2019
revised: 21 05 2019
accepted: 27 05 2019
pubmed: 30 5 2019
medline: 12 2 2020
entrez: 30 5 2019
Statut: epublish

Résumé

GCN5L1 regulates protein acetylation and mitochondrial energy metabolism in diverse cell types. In the heart, loss of GCN5L1 sensitizes the myocardium to injury from exposure to nutritional excess and ischemia/reperfusion injury. This phenotype is associated with the reduced acetylation of metabolic enzymes and elevated mitochondrial reactive oxygen species (ROS) generation, although the direct molecular targets of GCN5L1 remain largely unknown. In this study, we sought to determine the mechanism by which GCN5L1 impacts energy substrate utilization and mitochondrial health. We find that hypoxia and reoxygenation (H/R) leads to a reduction in cell viability and Akt phosphorylation in GCN5L1 knockdown AC16 cardiomyocytes, in parallel with elevated glucose utilization and impaired fatty acid use. We demonstrate that glycolysis is uncoupled from glucose oxidation under normoxic conditions in GCN5L1-depleted cells. We show that GCN5L1 directly binds to the Akt-activating mTORC2 component Rictor, and that loss of Rictor acetylation is evident in GCN5L1 knockdown cells. Finally, we show that restoring Rictor acetylation in GCN5L1-depleted cells reduces mitochondrial ROS generation and increases cell survival in response to H/R. These studies suggest that GCN5L1 may play a central role in energy substrate metabolism and cell survival via the regulation of Akt/mTORC2 signaling.

Identifiants

pubmed: 31138772
pii: BCJ20190302
doi: 10.1042/BCJ20190302
pmc: PMC6636327
mid: NIHMS1040780
doi:

Substances chimiques

BLOC1S1 protein, mouse 0
Mitochondrial Proteins 0
Nerve Tissue Proteins 0
Rapamycin-Insensitive Companion of mTOR Protein 0
rictor protein, mouse 0
Mechanistic Target of Rapamycin Complex 2 EC 2.7.11.1
Proto-Oncogene Proteins c-akt EC 2.7.11.1
Glucose IY9XDZ35W2

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1713-1724

Subventions

Organisme : NHLBI NIH HHS
ID : R01 HL132917
Pays : United States
Organisme : NHLBI NIH HHS
ID : R56 HL132917
Pays : United States
Organisme : NHLBI NIH HHS
ID : T32 HL110849
Pays : United States

Informations de copyright

© 2019 The Author(s). Published by Portland Press Limited on behalf of the Biochemical Society.

Références

J Cell Sci. 2018 Nov 20;131(22):
pubmed: 30333138
Can J Physiol Pharmacol. 2012 Aug;90(8):1135-44
pubmed: 22809038
J Mol Cell Cardiol. 1991 Sep;23(9):1077-86
pubmed: 1658348
J Biol Chem. 2014 Jan 31;289(5):2864-72
pubmed: 24356961
Am J Physiol Heart Circ Physiol. 2017 Aug 1;313(2):H265-H274
pubmed: 28526709
Cardiovasc Res. 2002 Aug 15;55(3):672-80
pubmed: 12160964
J Mol Cell Cardiol. 2012 Aug;53(2):233-9
pubmed: 22659291
Cell Death Differ. 2017 Apr;24(4):731-746
pubmed: 28211872
Biochem J. 2012 May 1;443(3):655-61
pubmed: 22309213
Circulation. 1997 Jan 21;95(2):313-5
pubmed: 9008441
FEBS Lett. 1998 Sep 4;434(3):305-8
pubmed: 9742943
Curr Biol. 2004 Jul 27;14(14):1296-302
pubmed: 15268862
Circulation. 2004 Mar 30;109(12):1550-7
pubmed: 15023869
Proc Natl Acad Sci U S A. 2015 Jul 28;112(30):9406-11
pubmed: 26170313
J Biol Chem. 2006 Sep 15;281(37):27643-52
pubmed: 16847060
Biochemistry. 1996 Nov 26;35(47):14923-31
pubmed: 8942657
FASEB J. 2005 Jun;19(8):983-5
pubmed: 15802488
Cardiovasc Res. 2015 Sep 1;107(4):499-508
pubmed: 26150203
Sci Transl Med. 2017 Oct 11;9(411):
pubmed: 29021167
Cardiovasc Res. 2014 Jan 1;101(1):30-8
pubmed: 24048945
J Physiol Biochem. 2015 Dec;71(4):623-33
pubmed: 26342597
Mol Metab. 2014 Jun 27;3(6):630-41
pubmed: 25161886
Circ Res. 1996 Nov;79(5):940-8
pubmed: 8888686
Methodist Debakey Cardiovasc J. 2009;5(3):2-7
pubmed: 20308957
Nat Cell Biol. 2013 Dec;15(12):1464-72
pubmed: 24212091
Circulation. 2013 Nov 5;128(19):2132-44
pubmed: 24008870
Arch Pharm Res. 2017 May;40(5):640-654
pubmed: 28378219
Proc Natl Acad Sci U S A. 1996 Sep 3;93(18):9893-8
pubmed: 8790427
J Mol Cell Cardiol. 2015 Jan;78:80-9
pubmed: 25281838
Cardiovasc Res. 2012 May 1;94(2):359-69
pubmed: 22436846
J Mol Cell Cardiol. 2005 Jul;39(1):133-47
pubmed: 15913645
Nat Commun. 2017 Sep 12;8(1):523
pubmed: 28900165
Mol Cell Biochem. 2004 Aug;263(1-2):131-6
pubmed: 15524173
Am J Physiol Cell Physiol. 2004 Oct;287(4):C817-33
pubmed: 15355853
Cell. 1997 Jun 27;89(7):1145-53
pubmed: 9215636
Am J Physiol Endocrinol Metab. 2017 Nov 1;313(5):E577-E585
pubmed: 28325730
J Mol Cell Cardiol. 2019 Apr;129:69-78
pubmed: 30776374
J Biol Chem. 1998 May 15;273(20):12662-8
pubmed: 9575229
PLoS One. 2013 Jul 26;8(7):e69910
pubmed: 23922853
J Biol Chem. 2012 Jan 2;287(1):581-8
pubmed: 22084251
Am J Physiol Cell Physiol. 2004 Nov;287(5):C1418-25
pubmed: 15294852
Am J Physiol Heart Circ Physiol. 2007 Jul;293(1):H354-65
pubmed: 17337596
Toxicol In Vitro. 2015 Aug;29(5):953-61
pubmed: 25835517
Scand Cardiovasc J. 2019 Feb;53(1):42-47
pubmed: 30160187
Am J Physiol Heart Circ Physiol. 2007 Dec;293(6):H3524-31
pubmed: 17906102
Cancer Biomark. 2017 Dec 6;20(4):581-588
pubmed: 28946557
Cardiovasc Res. 2014 Jan 1;101(1):57-68
pubmed: 24081164
Toxicology. 2017 May 1;382:108-116
pubmed: 28288859
Cell Death Dis. 2018 Jun 20;9(7):723
pubmed: 29925877
Circulation. 2006 Oct 17;114(16):1721-8
pubmed: 17030679

Auteurs

Janet R Manning (JR)

Division of Cardiology, Department of Medicine, University of Pittsburgh, Pittsburgh, PA, U.S.A.
Vascular Medicine Institute, Department of Medicine, University of Pittsburgh, Pittsburgh, PA, U.S.A.
Center for Metabolism and Mitochondrial Medicine, Department of Medicine, University of Pittsburgh, Pittsburgh, PA, U.S.A.

Dharendra Thapa (D)

Division of Cardiology, Department of Medicine, University of Pittsburgh, Pittsburgh, PA, U.S.A.
Vascular Medicine Institute, Department of Medicine, University of Pittsburgh, Pittsburgh, PA, U.S.A.
Center for Metabolism and Mitochondrial Medicine, Department of Medicine, University of Pittsburgh, Pittsburgh, PA, U.S.A.

Manling Zhang (M)

Division of Cardiology, Department of Medicine, University of Pittsburgh, Pittsburgh, PA, U.S.A.
Vascular Medicine Institute, Department of Medicine, University of Pittsburgh, Pittsburgh, PA, U.S.A.
Center for Metabolism and Mitochondrial Medicine, Department of Medicine, University of Pittsburgh, Pittsburgh, PA, U.S.A.

Michael W Stoner (MW)

Division of Cardiology, Department of Medicine, University of Pittsburgh, Pittsburgh, PA, U.S.A.
Vascular Medicine Institute, Department of Medicine, University of Pittsburgh, Pittsburgh, PA, U.S.A.
Center for Metabolism and Mitochondrial Medicine, Department of Medicine, University of Pittsburgh, Pittsburgh, PA, U.S.A.

Javier Traba (J)

Laboratory of Mitochondrial Biology and Metabolism, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, U.S.A.

Catherine Corey (C)

Vascular Medicine Institute, Department of Medicine, University of Pittsburgh, Pittsburgh, PA, U.S.A.
Center for Metabolism and Mitochondrial Medicine, Department of Medicine, University of Pittsburgh, Pittsburgh, PA, U.S.A.
Department of Pharmacology and Chemical Biology, University of Pittsburgh, Pittsburgh, PA, U.S.A.

Sruti Shiva (S)

Vascular Medicine Institute, Department of Medicine, University of Pittsburgh, Pittsburgh, PA, U.S.A.
Center for Metabolism and Mitochondrial Medicine, Department of Medicine, University of Pittsburgh, Pittsburgh, PA, U.S.A.
Department of Pharmacology and Chemical Biology, University of Pittsburgh, Pittsburgh, PA, U.S.A.

Michael N Sack (MN)

Laboratory of Mitochondrial Biology and Metabolism, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, U.S.A.

Iain Scott (I)

Division of Cardiology, Department of Medicine, University of Pittsburgh, Pittsburgh, PA, U.S.A. scotti2@upmc.edu.
Vascular Medicine Institute, Department of Medicine, University of Pittsburgh, Pittsburgh, PA, U.S.A.
Center for Metabolism and Mitochondrial Medicine, Department of Medicine, University of Pittsburgh, Pittsburgh, PA, U.S.A.

Articles similaires

Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Odour generalisation and detection dog training.

Lyn Caldicott, Thomas W Pike, Helen E Zulch et al.
1.00
Animals Odorants Dogs Generalization, Psychological Smell
Animals TOR Serine-Threonine Kinases Colorectal Neoplasms Colitis Mice
Animals Tail Swine Behavior, Animal Animal Husbandry

Classifications MeSH